General Practice · Bronx, NY
NPI
1891998225
Since 2007
Specialty
General Practice
Code 208D00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
1571 Sheridan Ave, Suite 4b
Bronx, NY, 10457
Phone (718) 466-0430
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$207K
658 prescriptions
Company payments, 2025
$158
From 3 companies
Medicare prescription drug claims, 2024
In 2024, the drug Emancia Neil prescribed most often to Medicare patients was Metformin Hcl, with 65 prescriptions and refills. In total Emancia Neil wrote 658 Medicare prescriptions that cost $207K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Metformin Hcl Generic | 65 | 93 | 14 | $337 |
| Pioglitazone Hcl Generic | 60 | 86 | 15 | $447 |
| Ozempic Semaglutide | 49 | 54 | Under 11 | $50K |
| Amlodipine Besylate Generic | 37 | 85 | 12 | $232 |
| Ramipril Generic | 31 | 47 | Under 11 | $140 |
| Ezetimibe-Simvastatin Ezetimibe/Simvastatin | 30 | 48 | Under 11 | $1,027 |
| Mounjaro Tirzepatide | 30 | 48 | Under 11 | $51K |
| Trulicity Dulaglutide | 25 | 25 | Under 11 | $23K |
| Vitamin D2 Ergocalciferol (Vitamin D2) | 24 | 28 | Under 11 | $26.56 |
| Carvedilol Generic | 21 | 51 | Under 11 | $213 |
| Omeprazole Generic | 19 | 29 | Under 11 | $65.31 |
| Losartan Potassium Generic | 17 | 37 | Under 11 | $198 |
| Simvastatin Generic | 14 | 26 | Under 11 | $119 |
| Losartan-Hydrochlorothiazide Losartan/Hydrochlorothiazide | 13 | 27 | Under 11 | $117 |
| Cyanocobalamin Injection Cyanocobalamin (Vitamin B-12) | 13 | 13 | Under 11 | $104 |
Brand drugs: 137 claims; generic drugs: 505 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Emancia Neil $158 ($158 in general payments such as food, travel and fees) from 3 companies. The largest payer was Novo Nordisk Inc with $72.88.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.